Laura Gault

VP of Neurology Clinical Development at Alexion

Speaker

• More than 10 years of pharmaceutical industry experience leading projects with small molecules, biologics and drug-device combinations at early and late stages of CNS development, including compounds in development for Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Progressive Supranuclear Palsy, Spinal Cord Injury, Friedreich’s Ataxia, Schizophrenia, and Attention-Deficit/Hyperactivity Disorder
• Experienced in development of long-range strategy for the Neuroscience Therapeutic Area to support advancement of pipeline products and to identify business development opportunities
• Skilled leader of global cross-functional teams that determine product strategy with integration of clinical development, regulatory and commercial recommendations
• Established track record of providing innovative clinical trial designs and delivering interpretable results in multinational trials according to established timelines
• Proficient in interactions with key external stakeholders, including regulators, key opinion leaders, and scientific consortia and presentations at international scientific meetings